Abstract
Thalidomide in front line treatment in multiple myeloma: serious risk of venous thromboembolism and evidence for thromboprophylaxis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1111/j.1538-7836.2004.00931.x
Publication Date: Nov 1, 2004 | |
Citations: 28 | License type: publisher-specific-oa |
Thalidomide in front line treatment in multiple myeloma: serious risk of venous thromboembolism and evidence for thromboprophylaxis
Join us for a 30 min session where you can share your feedback and ask us any queries you have